سهم تغيير تاريخ
Agios Pharmaceuticals USD 37.84M 2.09M 2026-09
ALKERMES USD 261.1M 37.86M 2026-09
Amgen USD 6.39B 169M 2026-09
Baxter International USD 2.3B 41M 2026-09
BioCryst Pharmaceuticals USD 13.74M 7.68M 2026-09
Biogen USD 2.22B 159.9M 2026-09
Bristol-Myers Squibb USD 2.7B 33M 2026-09
Cara Therapeutics USD 900K 0 2025-03
Cipla INR 67.78B 1.82B 2026-09
Dr.Reddys Laboratories INR 80.47B 3.94B 2026-06
Eisai JPY 272.61B 15.06B 2026-09
Eli Lilly USD 18.19B 1.4B 2026-09
Exelixis USD 29.87M 1.14M 2026-09
Gilead Sciences USD 1.9B 57M 2026-09
GlaxoSmithKline GBP 6.28B 125M 2026-06
Grifols EUR 3.56B 63.19M 2024-12
Halozyme Therapeutics USD 132.61M 4.52M 2026-09
Incyte USD 134.25M 21.71M 2026-09
Ionis Pharmaceuticals USD 28.58M 22.26M 2026-09
Karyopharm Therapeutics USD 4.04M 72K 2025-12
MacroGenics USD 9.5M 1.59M 2026-03
Merck USD 6.16B 43M 2026-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 66.1M 38.1M 2026-09
Novartis USD 6.1B 116M 2026-09
Pfizer USD 10.02B 77M 2026-09
Roche Holding CHF 7.6B 9M 2025-06
Sarepta Therapeutics USD 876.12M 28.15M 2026-09
Takeda JPY 1.44T 6.17B 2026-09
Teva Pharmaceutical Industries USD 3.17B 48M 2026-09